Mini review · 30 May 2023
Conference abstractPublished 6 May 2022
Neurovascular dysfunction in covid-19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Viral infection is initiated from the surface spike glycoprotein, which binds to ACE2 receptor in brain vascular endothelium and smooth muscle cells and enter the cells by endocytosis. After priming by TMPRSS2 (transmembrane protease serine 2), it is activated and then internalized, results in an imbalance in homeostatic procoagulant and anticoagulant pathways, Cytokine storm, endothelial dysfunction and dysregulated activation of macrophages contributes to hyperinflammation and thrombosis. Overactivation of NADPH oxidase-2 (Nox2), resulting in increased reactive oxidant species, is implicated in arterial vasoconstriction, clotting, and platelet activation. Virus directly infecting stromal cells via interaction with CD13 or CD66a adhesion molecules andinduce platelet aggregation via PAC-1 binding. Persisting changes of blood cell physical phenotypes contribute to long-term microcirculatory dysfunction. Cytokines induce cytoskeletal changes in myeloid cells and erythrocytes and impaired oxygen delivery. In severe COVID-19, lowdensity phenotype that is prone to neutrophil extracellular trap formation (NET), with elevated size and deformability as a source of vascular occlusion. Sars-CoV-2 propagates in hematopoietic progenitor, erythroid, and megakaryocytic cells as the main cause of thrombotic events. Viral cytopathic effects in peripheral smear and the peculiar morphological findings would suspect a diagnosis in the absence of a negative RT-PCR or antibody results. The coagulopathy characterized by an increase in procoagulant factors such as fibrinogen with a strong increase of D-dimers have been associated with higher mortality. The incidence of cerebral infarction in COVID-19 is 4.5%. Thromboprophylaxis with LMWHs is recommended in hospitalized patients with high levels of D-dimer indicating hypercoagulative state. Intravenous recombinant tissue plasminogen activator (rt-PA) for selected patients. MSCs therapy could help to cure the inflammation and coagulopathy by a vascular effect. Very small embryonic like stem cells (VSELs) have endothelial angiogenic potential. Exogenous ACE2 with human recombinant soluble ACE2 is a novel treatment for stroke and reverse endothelial dysfunction. JAK inhibitors reduce hyperinflammation.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 30 Dec 2022
Neurovascular Coupling Dysfunction and Types of Traumatic Brain Injury
Perspective · 28 Jun 2024
Thyroid Dysfunction in Long COVID-19: Mechanisms and Management Strategies
Review article · 2023
Drug-Induced Causes of Renal Damage and Dysfunction in Patients with Complicated COVID-19
Mini review · 29 Dec 2022
Efficacy of Intranasal Corticosteroids for Prevention of Persistent Olfactory Dysfunction in Covid-19 Patients: Meta-Analysis of Randomized Controlled Trials
More from this journal
The newest in Journal of Neurology and Clinical Neuroscience.
Article · 26 Mar 2025
Plasma-to-autopsy study of neurodegenerative diseases
Article · 30 Jan 2024
Are the pharmaceutical or alternative treatments most effective to treat Alzheimer's disease?
Article · 27 Jan 2024
Diplopia: A unique presenting symptom of neurobrucellosis – A case report
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neurology and Clinical Neuroscience
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ramachandran Muthiah”

